Once we identified the SK-OV-3-MDR-1-6/6 and NCI/ADR-RES cell lines as MDR1-expressing ovarian cancer models, we assessed the potency and efficacy of taccalonolide AF in these lines and their respective isogenic parental lines using the sulforhodamine B assay. This evidence concerns the gene ABCB1 and ovarian carcinoma.